Related Experiment Videos
Electroporation-mediated pain-killer gene therapy for mononeuropathic rats
1Department of Biological Sciences, National Sun Yat-Sen University, Taiwan.
Abstract:
The relatively low expression levels achieved from transferred genes have limited the application of nonviral vectors for gene transfer into the spinal cord in vivo. Thus, the aim of this study was to evaluate the efficacy of electroporation-mediated pro-opiomelanocortin (POMC) gene therapy for neuropathic pain using an animal model of chronic constrictive injury (CCI). Firstly, the optimal pulse characteristics (voltage, pulse duration, number of shocks) were investigated for in vivo electroporation-mediated gene transfer into the spinal cord. The electroporation process makes use of plasmid DNA, which expresses the POMC gene. Expression levels were evaluated in this study by Western blot. We conclude that the optimal conditions for electroporation are a pulse voltage of 200 V, 75-ms duration, 925-ms interval, for five iterations. Secondly, electroporation treatment for neuropathic pain was attempted on CCI rats using plasmid DNA that expresses the POMC gene. Intrathecal administrations of the POMC vector elevated spinal beta-endorphin levels, as manifested in a significantly elevated pain threshold for the CCI limbs. This result suggests that gene therapy for neuropathic pain using this novel technique is very efficacious, and thus shows promise for further clinical trials.
Insights
Electroporation enhanced gene therapy for neuropathic pain. This method successfully increased pro-opiomelanocortin (POMC) gene expression in the spinal cord, significantly improving pain thresholds in animal models.
Area of Science:
- Neuroscience
- Molecular Biology
- Gene Therapy
Background:
- Nonviral gene transfer to the spinal cord faces challenges due to low gene expression levels.
- Neuropathic pain, often resulting from chronic constrictive injury (CCI), requires effective therapeutic strategies.
Purpose of the Study:
- To optimize electroporation parameters for efficient in vivo gene transfer into the spinal cord.
- To evaluate the efficacy of electroporation-mediated pro-opiomelanocortin (POMC) gene therapy for neuropathic pain in a CCI rat model.
Main Methods:
- Investigated optimal electroporation conditions (voltage, duration, interval, iterations) for spinal cord gene transfer.
- Utilized plasmid DNA expressing the POMC gene.
- Assessed gene expression via Western blot and pain thresholds in CCI rats.
Main Results:
- Determined optimal electroporation parameters: 200 V, 75-ms duration, 925-ms interval, five iterations.
- Intrathecal administration of POMC gene therapy via electroporation significantly elevated spinal beta-endorphin levels.
- Demonstrated a significant increase in pain threshold in the affected limbs of CCI rats.
Conclusions:
- Electroporation provides an effective method for enhancing gene transfer into the spinal cord.
- POMC gene therapy delivered via electroporation shows significant efficacy in alleviating neuropathic pain.
- This approach holds promise for future clinical applications in pain management.